ATE263761T1 - 5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel - Google Patents

5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel

Info

Publication number
ATE263761T1
ATE263761T1 AT01114943T AT01114943T ATE263761T1 AT E263761 T1 ATE263761 T1 AT E263761T1 AT 01114943 T AT01114943 T AT 01114943T AT 01114943 T AT01114943 T AT 01114943T AT E263761 T1 ATE263761 T1 AT E263761T1
Authority
AT
Austria
Prior art keywords
derivatives
dihydropyron
protease inhibitors
antiviral agents
present
Prior art date
Application number
AT01114943T
Other languages
German (de)
English (en)
Inventor
Edmund L Ellsworth
Elizabeth Lunney
Bradley Dean Tait
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,820 external-priority patent/US5840751A/en
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Application granted granted Critical
Publication of ATE263761T1 publication Critical patent/ATE263761T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT01114943T 1993-11-19 1994-10-26 5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel ATE263761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15544393A 1993-11-19 1993-11-19
US08/319,820 US5840751A (en) 1993-11-19 1994-10-12 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (1)

Publication Number Publication Date
ATE263761T1 true ATE263761T1 (de) 2004-04-15

Family

ID=26852338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01114943T ATE263761T1 (de) 1993-11-19 1994-10-26 5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel

Country Status (18)

Country Link
EP (1) EP0729464A1 (no)
JP (1) JP3684426B2 (no)
AT (1) ATE263761T1 (no)
AU (1) AU689158B2 (no)
CA (1) CA2176043A1 (no)
DE (1) DE69433705T2 (no)
DK (1) DK1142887T3 (no)
ES (1) ES2219457T3 (no)
FI (1) FI962022A7 (no)
HR (1) HRP940935B1 (no)
HU (1) HUT77668A (no)
IL (1) IL111674A0 (no)
NO (1) NO316172B1 (no)
NZ (1) NZ275961A (no)
PT (1) PT1142887E (no)
RU (1) RU2140917C1 (no)
SI (1) SI1142887T1 (no)
WO (1) WO1995014012A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100693944B1 (ko) * 1995-08-11 2007-03-12 제논 인바이런멘탈 인코포레이티드 수직한 중공사 멤브레인 다발 및 섬유 표면을 깨끗하게유지시키는 방법
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
JP4462760B2 (ja) * 1997-09-11 2010-05-12 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法
KR20010085780A (ko) * 1998-09-11 2001-09-07 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Hiv 프로테아제 억제제
US6288235B1 (en) 1999-04-14 2001-09-11 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries
DE10030094A1 (de) * 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
US7141681B2 (en) 2001-02-22 2006-11-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Continuous process for preparing dihydropyrones
DE10108471C1 (de) 2001-02-22 2002-11-21 Boehringer Ingelheim Pharma Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
TW200307667A (en) 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
SE0302487D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
UA88909C2 (ru) 2004-08-18 2009-12-10 Пфайзер Инк. Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение
DE102005059469A1 (de) 2005-12-13 2007-06-14 Bayer Cropscience Ag Insektizide Zusammensetzungen mit verbesserter Wirkung
DE102006007882A1 (de) 2006-02-21 2007-08-30 Bayer Cropscience Ag Cycloalkyl-phenylsubstituierte cyclische Ketoenole
HRP20110845T1 (hr) * 2006-06-16 2011-12-31 Pharma Mar Antitumorski dihidropiran-2-onski spojevi
CN102348684B (zh) 2009-03-11 2014-11-12 拜尔农作物科学股份公司 被卤代烷基亚甲基氧基苯基取代的酮烯醇
DE102010008644A1 (de) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Zyklische Ketoenole zur Therapie
RU2461555C1 (ru) * 2011-07-07 2012-09-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" Способ получения 5-арил-3-фенил-2-оксаспиро[5,6]додец-3-ен-1-онов, проявляющих анальгетическую активность
KR102030337B1 (ko) 2012-01-26 2019-10-10 바이엘 인텔렉쳐 프로퍼티 게엠베하 어류 기생충 방제용의 페닐-치환된 케토에놀
KR20150090912A (ko) 2012-11-28 2015-08-06 스미또모 가가꾸 가부시끼가이샤 디히드로피론 화합물 및 상기를 포함하는 제초제
SE539512C2 (sv) * 2015-12-02 2017-10-03 Ultupharma Ab Compounds and methods of treating bacterial infections
CN115916752B (zh) * 2020-06-26 2025-05-06 日本农药株式会社 芳基四氢吡啶衍生物或其盐类、和含有该化合物的杀虫剂及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
CH617569A5 (en) * 1975-09-29 1980-06-13 Ciba Geigy Ag Pesticides containing, as active ingredient, a 3-N-phenyl-carbamoyl-4-hydroxy-1,2-(benzo)pyrone derivative.
SU950728A1 (ru) * 1981-01-23 1982-08-15 Пермский государственный фармацевтический институт Способ получени 6-арил-3-ароил-4-окси-5-бромпиран-2-онов
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses

Also Published As

Publication number Publication date
FI962022L (fi) 1996-07-12
ES2219457T3 (es) 2004-12-01
FI962022A0 (fi) 1996-05-13
DE69433705D1 (de) 2004-05-13
PT1142887E (pt) 2004-08-31
DK1142887T3 (da) 2004-06-21
AU8125694A (en) 1995-06-06
SI1142887T1 (en) 2004-08-31
FI962022A7 (fi) 1996-07-12
NO316172B1 (no) 2003-12-22
HRP940935A2 (en) 1997-04-30
AU689158B2 (en) 1998-03-26
WO1995014012A1 (en) 1995-05-26
HU9601348D0 (en) 1996-07-29
JP3684426B2 (ja) 2005-08-17
RU2140917C1 (ru) 1999-11-10
NZ275961A (en) 2001-11-30
NO962017L (no) 1996-07-08
CA2176043A1 (en) 1995-05-26
IL111674A0 (en) 1995-01-24
JPH09505294A (ja) 1997-05-27
NO962017D0 (no) 1996-05-15
DE69433705T2 (de) 2005-03-10
EP0729464A1 (en) 1996-09-04
HUT77668A (hu) 1998-07-28
HRP940935B1 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
ATE263761T1 (de) 5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel
PT729463E (pt) Derivados de 5,6-dihidropirona como inibidores de protease e agentes antivirais
MY138860A (en) Hiv protease inhibitors.
FI915819A0 (fi) Hiv- proteas-inhibitorer.
MD960171A (ro) Derivaţi ai pironei folosiţi ca inhibitori ai proteazei şi agenţi antivirali
HU9601350D0 (en) Pyrone derivatives as protease inhibitors and antiviral agents
WO1995014014A3 (en) Pyrone derivatives as protease inhibitors and antiviral agents
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1142887

Country of ref document: EP

REN Ceased due to non-payment of the annual fee